LGS Innovations Wins $11.2M Contract to Develop Laser for Detecting Chemical Residue

Kevin Kelly, LGS Innovations

Kevin Kelly, LGS Innovations

LGS Innovations announced April 18 it has been awarded a four-year, $11.2M cost-plus-fixed-fee contract to develop a compact, laser-based system to aid in the detection of chemical weapons, biological agents, explosives, narcotics and chemical indicators of nuclear material development.

“LGS has been focused on developing the most advanced laser and photonic-based solutions for decades,” LGS Innovations CEO Kevin Kelly said. “We are excited to leverage our proven experience to field a state-of-the-art prototype that will help our armed forces detect an incredible range of substances safely and discretely.”

“This program has the potential to be extremely influential in the future of laser technology and threat prevention,” LGS Innovations Photonics Applications & Development Director Dr. Linda Braun said. “LGS is looking forward to applying our expertise in laser systems to this important and challenging project.”
For this project, the University of Illinois will be the subcontractor contributing detection algorithm expertise.

The U.S. Air Force Research Laboratory at Wright-Patterson Air Force Base, Ohio, announced that LGS Innovations will be one of four performers chosen to develop the system for the U.S. Intelligence Advanced Research Projects Activity (IARPA). The contract is in support of IARPA’s Standoff Illuminator for Measuring Absorbance and Reflective Infrared Light Signatures (SILMARILS) project.

LGS will be responsible for developing a real-time, standoff solution capable of detecting trace chemical residues on surfaces from up to 30 meters using active infrared spectroscopy. LGS will develop the physical hardware as well as the detection and discrimination algorithms for a field-testable prototype for the U.S. federal government.

Once completed, the system will have broad application both in the physical security space, as well as the fight against the manufacture and trafficking of illicit drugs.

Related: Douglas Manya Named General Counsel at LGS Innovations

InCadence BANNER AD

Comments are closed.